D. Jarlais

发表

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Bernadette A. Thomas, Alan D. Lopez, Michael K. Freeman, 2012, The Lancet.

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition

Nobhojit Roy, Ronan A Lyons, Peilin Shi, 2015, The Lancet.

A community-based intervention to decrease the prevalence of HIV viremia among people who inject drugs in Vietnam

J. Molès, P. Van de Perre, N. Nagot, 2022, The Lancet regional health. Western Pacific.

AIDS Prevention Programs for Intravenous Drug Users: diversity and evolution

D. D. Jarlais, D. Jarlais, 1989 .

HIV prevention in developed countries

P. Aggleton, D. D. Jarlais, M. Schechter, 1996, The Lancet.

Understanding the long-term course of HIV epidemics.

D. Jarlais, 1998 .

Development and implementation of a cross-border HIV prevention intervention for injection drug users in Ning Ming County (Guangxi Province), China and Lang Son Province, Vietnam

T. Hammett, Wei Liu, N. D. Tung, 2003 .

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Alan D. Lopez, Stephen S. Lim, R. Malekzadeh, 2012, The Lancet.

Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016

Eyal Oren, Laith J. Abu-Raddad, Mark Strong, 2017, Lancet.

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

Ashutosh Kumar Singh, Dan J Stein, Mohammad Sadegh Hassanvand, 2016, Lancet.

High-risk behaviors and their association with awareness of HIV status among participants of a large-scale prevention intervention in Athens, Greece

A. Hatzakis, K. Pantavou, G. Nikolopoulos, 2020, BMC Public Health.

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

Louisa Degenhardt, Don Des Jarlais, Holly Hagan, 2011, The Lancet.

Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand

J. Esparza, T. Mastro, W. Heyward, 2001, AIDS.

Hepatitis C virus infection among HIV-positivemen who have sex with men: protocol for asystematic review and meta-analysis

H. Hagan, R. Braithwaite, K. Dombrowski, 2014 .

Interventions to reduce the sexual risk behaviour of injecting drug users

Don C. Des Jarlais, D. D. Jarlais, S. Semaan, 2005 .

A meta-analytic review of HIV behavioral interventions for reducing sexual risk behavior of men who have sex with men.

Wei Liu, Ryan Kling, Don C. Des Jarlais, 2005 .

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Dan J Stein, Gunn Marit Aasvang, Bernadette A. Thomas, 2015, The Lancet.

Harm reduction.

J. Normand, Jih-Heng Li, N. Thomson, 2013, Journal of food and drug analysis.

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Bernadette A. Thomas, Alan D. Lopez, Michael K. Freeman, 2012, The Lancet.

HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987.

Samuel R. Friedman, Don C. Des Jarlais, S. Friedman, 1989, JAMA.

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Haniye Sadat Sajadi, David L. Smith, Dan J Stein, 2018, The Lancet.

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

Ashutosh Kumar Singh, Dan J Stein, Bernadette A. Thomas, 2016, Lancet.

Compliance with hepatitis B vaccination in 1175 heroin users and risk factors associated with lack of vaccine response.

D. D. Jarlais, A. Lechi, G. Talamini, 2002, Addiction.

HETEROSEXUAL PARTNERS: A LARGE RISK GROUP FOR AIDS

D. D. Jarlais, S. Friedman, M. Chamberland, 1984, The Lancet.

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Bernadette A. Thomas, Alan D. Lopez, Michael K. Freeman, 2012, The Lancet.

Harm reduction in the USA: the research perspective and an archive to David Purchase

D. D. Jarlais, D. Jarlais, 2017 .

Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?

Tara S. Beattie, D. D. Jarlais, P. Vickerman, 2013, Drug and alcohol dependence.

Intoxications, intentions, and disease preventions.

D. Jarlais, 1997 .

Economic Recession and Emergence of an HIV-1 Outbreak among Drug Injectors in Athens Metropolitan Area: A Longitudinal Study

A. Hatzakis, S. Friedman, A. Fotiou, 2013, PloS one.

Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Nobhojit Roy, Anders Larsson, Ivy Shiue, 2014, The Lancet.

Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Dan J Stein, T. H. Nguyen, Reed J. D. Sorensen, 2018, Lancet.

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Bernadette A. Thomas, Alan D. Lopez, Mark D. Huffman, 2015, The Lancet.

Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017

Dan J Stein, T. H. Nguyen, Vijay Kumar Chattu, 2019, The lancet. HIV.

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Dan J Stein, Gunn Marit Aasvang, Bernadette A. Thomas, 2015, BDJ.

Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

Eyal Oren, Laith J. Abu-Raddad, Qingyang Xiao, 2016, The Lancet.

Effective medical treatment of opiate addiction

W. H. Hall, J. R. Cooper, H. Hiatt, 1998 .

Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Dan J Stein, David L. Smith, Mohammad Sadegh Hassanvand, 2017, Lancet.

The Impact of Sexual Abuse: Implications for Drug Treatment

P. Friedmann, D. Paone, W. Chavkin, 1992 .

Cross-national studies of AIDS among injecting drug users

D. D. Jarlais, D. Jarlais, 1994 .

The first and second decades of AIDS among injecting drug users.

D. D. Jarlais, D. Jarlais, 1992 .

Law enforcement influences on HIV prevention for injection drug users:: Observations from a cross-border project in China and Vietnam

R. Broadhead, H. Quyen, T. Hammett, 2005 .

The transition from opium smoking to heroin injection in the United States

H. Joseph, D. Courtwright, D. Jarlais, 1991 .

Global, regional, and national levels of maternal mortality, 1990â€“2015: a systematic analysis for the Global Burden of Disease Study 2015

Eyal Oren, Qingyang Xiao, Joshua A. Salomon, 2016 .

Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta‐analysis

J. Rich, H. Hagan, C. Beckwith, 2013, Hepatology.

HIV risk behaviour among participants of syringe exchange programmes in central/eastern Europe and Russia

D. D. Jarlais, J. Grund, T. Perlis, 2002 .

Difficult-to-reuse needles for the prevention of HIV infection among injecting drug users

D. Jarlais, 1992 .

Comments on Stimson ’ s a Has the United Kingdom averted an epidemic of HIV-1 infection among drug injectors ? o

D. Jarlais, 2010 .

An International Systematic Review and Meta-analysis of Multisession Psychosocial Interventions Compared with Educational or Minimal Interventions on the HIV Sex Risk Behaviors of People Who Use Drugs

N. Meader, A. Llewellyn, S. Semaan, 2013, AIDS and Behavior.

Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens

A. Pharris, A. Hatzakis, S. Friedman, 2017, The Journal of infectious diseases.

Associations between methamphetamine use and lack of viral suppression among a cohort of HIV positive persons who inject drugs in hai phong vietnam.

J. Molès, K. Arasteh, N. Nagot, 2020, AIDS.

Ending HIV epidemics among people who inject drugs in LMICs

D. D. Jarlais, H. Duong, D. Jarlais, 2018, The Lancet.

Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

Ashutosh Kumar Singh, Dan J Stein, Mohammad Sadegh Hassanvand, 2016, Lancet.

Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Haniye Sadat Sajadi, David L. Smith, Dan J Stein, 2018, The Lancet.

To use or not to use: an update on licit and illicit ketamine use

Y. Cheung, R. Schottenfeld, Jih-Heng Li, 2011, Substance abuse and rehabilitation.

Modeling HIV transmission among persons who inject drugs (PWID) at the “End of the HIV Epidemic” and during the COVID-19 pandemic

G. Bobashev, J. Feelemyer, C. McKnight, 2022, Drug and Alcohol Dependence.

Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.

H. Hagan, Janetta M. Astone-Twerell, S. Strauss, 2008, The International journal on drug policy.

Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experiment

Bilal Khan, Ian Duncan, Daniel Smith, 2017, PloS one.

DECLINES IN PROPORTION OF KAPOSI'S SARCOMA AMONG CASES OF AIDS IN MULTIPLE RISK GROUPS IN NEW YORK CITY

S. Friedman, P. Thomas, R. Stoneburner, 1987, The Lancet.

P2-416 Estimating the prevalence of hepatitis B infection among people who inject drugs: results from a global systematic review

L. Degenhardt, H. Hagan, S. Kinner, 2011, Journal of Epidemiology & Community Health.

“Maintaining HIV and HCV prevention and care for people who inject drugs despite COVID‐19 in Hai Phong, Vietnam”

D. D. Jarlais, J. Molès, N. Nagot, 2022, International Journal of Drug Policy.

An improved HIV care cascade to assess HIV control programs among people who inject drugs.

J. Molès, K. Arasteh, N. Nagot, 2019 .

HIV Treatment Knowledge in the Context of “Treatment as Prevention” (TasP)

S. Braunstein, S. Tross, A. Campbell, 2020, AIDS and Behavior.

Public funding of US Syringe Exchange Programs

C. McKnight, J. Milliken, D. Jarlais, 2004, Journal of Urban Health.

Syringe exchange programs --- United States, 2008.

A. Lansky, K. Arasteh, D. Purchase, 2010, MMWR. Morbidity and mortality weekly report.

Vienna Declaration: a call for evidence-based drug policies

Julio S. G. Montaner, D. Nutt, D. D. Jarlais, 2010, The Lancet.

“It’s Never Just About the HIV:” HIV Primary Care Providers’ Perception of Substance Use in the Era of “Universal” Antiretroviral Medication Treatment

S. Tross, A. Campbell, L. Weaver, 2018, AIDS and Behavior.

Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia

A. Uusküla, D. M. Barnes, A. Talu, 2021, Harm Reduction Journal.

Combined HIV Prevention, the New York City Condom Distribution Program, and the Evolution of Safer Sex Behavior Among Persons Who Inject Drugs in New York City

D. Jarlais, 2014 .

Reasons People Who Use Opioids Do Not Accept or Carry No-Cost Naloxone: Qualitative Interview Study

Alex S. Bennett, D. D. Jarlais, D. D. Des Jarlais, 2020, JMIR formative research.

Psychiatric Comorbidities among People Who Inject Drugs in Hai Phong, Vietnam: The Need for Screening and Innovative Interventions

J. Molès, N. Nagot, R. Vallo, 2018, BioMed research international.

Patterns of HIV prevalence and HIV risk behaviors among injection drug users prior to and 24 months following implementation of cross-border HIV prevention interventions in northern Vietnam and southern China.

T. Hammett, R. Kling, P. Friedmann, 2006, AIDS education and prevention : official publication of the International Society for AIDS Education.

Another frontier for harm reduction: contraceptive needs of females who inject drugs in Estonia, a cross-sectional study

M. Raag, A. Uusküla, S. Vorobjov, 2018, Harm Reduction Journal.

Current state of U.S. syringe exchange programs: Success, new tasks, the financial crisis and the Affordable Care Act

D. Purchase, V. Guardino, A. Nugent, 2014 .

Gender Differences in HIV, HCV risk and Prevention Needs Among People who Inject drug in Vietnam.

J. Molès, N. Nagot, H. T. Giang, 2022, AIDS and behavior.

Towards Targeted Interventions in Low- and Middle-Income Countries: Risk Profiles of People Who Inject Drugs in Haiphong (Vietnam)

D. D. Jarlais, J. Molès, N. Nagot, 2020, BioMed research international.

Harm reduction--a framework for incorporating science into drug policy.

D. Jarlais, 1995 .

Evaluating Recruitment among Female Sex Workers and Injecting Drug Users at Risk for HIV Using Respondent-driven Sampling in Estonia

L. Johnston, D. D. Jarlais, M. Raag, 2010, Journal of Urban Health.

Should Pharmacists have a Role in Harm Reduction Services for IDUs? A Qualitative Study in Tallinn, Estonia

A. Uusküla, S. Vorobjov, A. Talu, 2009, Journal of Urban Health.

AddressingtheHIV/AIDSEpidemicAmongPuerto RicanPeopleWhoInjectDrugs:TheNeedfora MultiregionApproach

S. Deren, C. Gelpí-Acosta, C. Albizu-García, 2014 .

Hepatitis C Knowledge among Staff in U.S. Drug Treatment Programs

D. D. Jarlais, H. Hagan, Janetta M. Astone-Twerell, 2006, Journal of drug education.

Potential impact of HIV among IDUs on heterosexual transmission in Asian settings: scenarios from the Asian Epidemic Model

Tim Brown, Tobi Saidel, Don C. Des Jarlais, 2003 .

Research, politics, and needle exchange.

D. D. Jarlais, D. Jarlais, 2000 .

Preventing HIV infection among injecting drug users: Intuitive and counter-intuitive findings

D. Jarlais, 1999 .

HIV prevention and psychoactive drug use: a research agenda

D. D. Jarlais, S. Semaan, D. C. Jarlais, 2009, Journal of Epidemiology & Community Health.

PersistenceandChangeinDisparitiesinHIVInfection AmongInjectionDrugUsersinNewYorkCityAfter Large-ScaleSyringeExchangePrograms

H. Hagan, S. Friedman, K. Arasteh, 2009 .

The fentanyl epidemic in Estonia: factors in its evolution and opportunities for a comprehensive public health response, a scoping review.

A. Uusküla, A. Talu, L. Lemsalu, 2020, The International journal on drug policy.

HIV control programs reduce HIV incidence but not HCV incidence among people who inject drugs in HaiPhong, Vietnam

J. Molès, K. Arasteh, N. Nagot, 2020, Scientific Reports.

Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014

J. Molès, K. Arasteh, N. Nagot, 2018, AIDS and Behavior.

Systematic review research on needle/syringe programs and opiate substitution programs in low- and middle-income countries.

D. D. Jarlais, D. Jarlais, 2013, Journal of food and drug analysis.

HomelessnessandOtherRiskFactorsforHIVInfectionin theCurrentOutbreakAmongInjectionDrugUsersin Athens,Greece

A. Pharris, A. Hatzakis, S. Friedman, 2015 .

Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece.

D. D. Jarlais, A. Pharris, A. Hatzakis, 2015, American journal of public health.

Ethnicity and drug use among urban junior high school youths.

R. Dembo, J. Schmeidler, W. Burgos, 1979, The International journal of the addictions.

LONG‐TERM OUTCOMES AFTER TERMINATION FROM METHADONE MAINTENANCE TREATMENT *

H. Joseph, V. Dole, D. Jarlais, 1981, Annals of the New York Academy of Sciences.

Cross-sectional association between ZIP code-level gentrification and homelessness among a large community-based sample of people who inject drugs in 19 US cities

D. D. Jarlais, S. Friedman, Z. Ross, 2017, BMJ Open.

Risk for Heterosexual HIV Transmission Among Non-Injecting Female Partners of Injection Drug Users in Estonia

M. Kals, J. M. McMahon, A. Uusküla, 2013, AIDS and Behavior.

What predicts which metropolitan areas in the USA have syringe exchanges

S. Friedman, B. Tempalski, C. McKnight, 2003 .

Struggling to achieve a 'normal life': A qualitative study of Vietnamese methadone patients.

M. Jauffret-Roustide, N. Nagot, J. Feelemyer, 2019, The International journal on drug policy.

Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: an international systematic review.

D. D. Jarlais, H. Hagan, K. Arasteh, 2014, Drug and alcohol dependence.

An application of agent-based modeling to explore the impact of decreasing incarceration rates and increasing drug treatment access on sero-discordant partnerships among people who inject drugs.

Ross A. Hammond, Emma C Spencer, T. Finlayson, 2021, The International journal on drug policy.

Adherence to Antiretroviral Medications Among Persons Who Inject Drugs in Transitional, Low and Middle Income Countries: An International Systematic Review

A. Uusküla, K. Arasteh, J. Feelemyer, 2015, AIDS and Behavior.

Commentary on Grebely et al. (2019): Ending HCV epidemics among people who inject drugs.

D. Jarlais, 2019 .

Validity of self-reported data, scientific methods and drug policy

Don C. Des Jarlais, D. Jarlais, 1998 .

Condomi Availabilit in New York Cit Public High Schools : Relationships to Condom-Use and Sexual Behavior

D. D. Jarlais, S. Guttmacher, L. Lieberman, 2006 .

Prescription opioid misuse and its relation to injection drug use and hepatitis C virus infection: protocol for a systematic review and meta-analysis

H. Hagan, D. Jarlais, A. Jordan, 2014, Systematic Reviews.

Smoking characteristics and comorbidities in the power to quit randomized clinical trial for homeless smokers.

J. Connett, K. Resnicow, L. Gelberg, 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Dominican, Mexican, and Puerto Rican Prostitutes: Drug Use and Sexual Behaviors

M. Clatts, S. Deren, M. Shedlin, 1997, Hispanic journal of behavioral sciences.

High dose benzodiazepine dependence: Description of 29 patients treated with flumazenil infusion and stabilised with clonazepam

P. Verbanck, C. Pattaro, G. Gerra, 2012, Psychiatry Research.

The fentanyl epidemic in Estonia: opportunities for a comprehensive public health response.

S. Vorobjov, A. Uuskula, D. Jarlais, 2019, The lancet. Psychiatry.

Clinical Decision Making in a Central Intake Unit for Drug Abuse Treatment

A. Kott, D. Jarlais, 1981 .

Buprenorphine in maintenance treatment: experience among Italian physicians in drug addiction centers.

D. D. Jarlais, C. Pattaro, G. Gerra, 2010, The American journal on addictions.

A cohort study revealed high mortality among people who inject drugs in Hai Phong, Vietnam

J. Molès, N. Nagot, H. T. Giang, 2021, Journal of clinical epidemiology.

Racial and ethnic disparities and implications for the prevention of HIV among persons who inject drugs

D. D. Jarlais, A. Hatzakis, H. Hagan, 2012, Current opinion in HIV and AIDS.

Increasing HIV prevention and care for injecting drug users

K. Arasteh, Marya Gwadz, D. Jarlais, 2010, The Lancet.

The New York 911 Good Samaritan Law and Opioid Overdose Prevention Among People Who Inject Drugs

C. McKnight, Heidi Bramson, Cathy Zadoretzky, 2017 .

Department of Error

Reed J. D. Sorensen, Alan D. Lopez, Daniel C. Casey, 2017, The Lancet.

Erratum: Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1775–1812)(S0140673616314702)(10.1016/S0140-6736(16)31470-2))

Ashutosh Kumar Singh, Reed J. D. Sorensen, Alan D. Lopez, 2017 .

A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States.

D. D. Jarlais, H. Hagan, S. Strauss, 2004, Drug and alcohol dependence.

Addicts who survived

H. Joseph, D. Courtwright, D. Jarlais, 1989 .

Providing support to drug users infected with hepatitis C : The role of methadone maintenance treatment staff

H. Hagan, S. Strauss, Corrine E. Munoz-Plaza, 2005 .

Preventing HIV transmission among injecting drug users (IDUs) and from IDUs to noninjecting sexual partners in Sichuan, China.

D. Jarlais, 2007 .

Homeless Former Smokers' Interest in Helping Homeless Current Smokers Quit

J. Connett, Mignonne C. Guy, K. Okuyemi, 2012, American journal of health promotion : AJHP.

Stages in the Response of the Drug Abuse Treatment System to the AIDS Epidemic in New York City

D. Jarlais, 1990 .

On-Site HIV Testing in Residential Drug Treatment Units: Results of a Nationwide Survey

Z. Vassilev, S. Strauss, J. Astone, 2003, Public health reports.

A call to reprioritise metrics to evaluate illicit drug policy

Julio S. G. Montaner, D. Nutt, D. D. Jarlais, 2016, The Lancet.

Commentary on Zhou et al. (2015): Research on methadone maintenance treatment (MMT) as prevention for HCV infection - MMT is not a single variable

D. Jarlais, 2015 .

The Fear of Drugs Used by Strangers.

D. Jarlais, 2015 .

From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits.

H. Hagan, S. Tross, K. Arasteh, 2016, Journal of substance abuse treatment.

Haniye Sadat Sajadi, David L. Smith, Dan J Stein, 2018, Lancet.

Learning from HIV epidemics among injecting drug users.

D. Jarlais, 2010, The International journal on drug policy.

AssociationsBetweenHerpesSimplexVirusType2andHCV WithHIVAmongInjectingDrugUsersinNewYorkCity:The CurrentImportanceofSexualTransmissionofHIV

H. Hagan, K. Arasteh, D. Perlman, 2011 .

Residential Substance User Treatment Programs as Venues for HCV Pharmacological Treatment: Client and Staff Perspectives

D. D. Jarlais, H. Hagan, S. Strauss, 2005, Substance use & misuse.

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

B. Cowie, H. Hagan, P. Nelson, 2011, The Lancet.

Alan D. Lopez, Michael K. Freeman, Stephen S. Lim, 2012, The Lancet.

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

Bernadette A. Thomas, Daniel C. Casey, Kara Estep, 2016, Lancet.

Mitochondrial Genotoxicity of Hepatitis C Treatment among People Who Inject Drugs

D. D. Jarlais, J. Molès, N. Nagot, 2021, Journal of clinical medicine.

A meta-analytic review of HIV behavioral interventions for reducing sexual risk behavior of men who have sex with men.

T. Hammett, R. Kling, Wei Liu, 2005 .

H. Hagan, K. Arasteh, J. Feelemyer, 2014, Drug and alcohol dependence.

Experts’ estimates of coverage needed for interventions to control HIV transmisson among injecting drug users

D. Burrows, D. Jarlais, S. R. Friedman, 2007 .

Alan D. Lopez, Michael K. Freeman, Stephen S. Lim, 2012, The Lancet.

Gunn Marit Aasvang, Daniel C. Casey, D. Mozaffarian, 2015, The Lancet.

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Bernadette A. Thomas, Alan D. Lopez, Mark D. Huffman, 2015, The Lancet.

HIV vaccine trials [4]

M. Marmor, S. Vanichseni, D. Kitayaporn, 1998 .

PREDICTING POST-TREATMENT NARCOTIC USE AMONG PATIENTS TERMINATING FROM METHADONE MAINTENANCE

H. Joseph, V. Dole, J. Schmeidler, 1982 .

NATIONAL AND INTERNATIONAL ASPECTS OF DOING HARM REDUCTION BETTER

D. Jarlais, 2009 .

Global, Regional, and National Levels of Maternal Mortality, 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015

Ashutosh Kumar Singh, Reed J. D. Sorensen, Alan D. Lopez, 2017, Obstetrical & Gynecological Survey.

Social Science and AIDS

D. Jarlais, 1986 .

A Review of State Laws , Syringe Exchange and HIV among Persons Who Inject Drugs in the United States : History and Effectiveness Short Title : Syringe Exchange Law in the Unite States

K. Arasteh, Heidi Bramson, V. Guardino, 2014 .

Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015

Reed J. D. Sorensen, Daniel C. Casey, L. Dandona, 2016 .

Research Design, Drug Use, and Deaths: Cross Study Comparisons

D. Jarlais, 1984 .

DSM-5 substance use disorder symptom clusters and HIV antiretroviral therapy (ART) adherence

D. D. Jarlais, M. Pavlicova, S. Tross, 2020, AIDS Care.